A Resource for Healthcare and Social Services Professionals
Attend a free live training event! Browse trainings by topic, month, or event format (virtual or in-person), and then be sure to register online. Please note this list of upcoming trainings is updated regularly. If you do not see a specific training listed below, please check back or email us with any questions. If you want to be notified of newly booked trainings, subscribe to our mailing list.
DEA-eligible
Topic: Buprenorphine
This two-part training is intended to provide eight hours of required training for providers seeking their buprenorphine waivers.
 |
Friday, 12/9/2022 8:00 am – 12:00 pm ET |
 |
Virtual event |
 |
Intended AudiencePhysicians (MD, DO), Nurse Practitioners, Certified Nurse Midwives (CNM), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), and Physician Assistants |
Topic: Nurse Care Manager Model
This 8-hour course prepares nurses and other medical staff to manage office-based addiction treatment with buprenorphine and naltrexone.
|
Monday, 12/12/2022 10:00 am – 2:00 pm ET |
|
Virtual event |
|
Intended AudienceNurses and other clinical staff providing treatment for substance use disorders in an office-based setting. |
Topic: CARN and CARN-AP
This no-cost course reviews topics covered in the certification exam for addictions nursing and is intended to support nurses preparing to sit for the exam.
|
Monday, 12/12/2022 4:00 pm – 8:00 pm ET |
|
Virtual event |
|
Intended AudienceRegistered Nurses (RNs) and Advanced Practice Registered Nurses (APRNs), with experience treating patients with addiction, who intend to sit for the CARN or CARN-AP exam. |
Topic: Stimulants
This training will provide an introduction to stimulant use disorder.
|
Tuesday, 12/13/2022 12:00 pm – 1:00 pm ET |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Topic: Family & Social Supports
This training will highlight the importance of family and social support for people with SUD. The importance of evidence-based resources for families will be explained. And concrete and simple changes to current models of addiction treatment to engage the family will be introduced.
|
Wednesday, 12/14/2022 12:00 pm – 1:00 pm ET |
|
Virtual event |
|
Intended AudienceAll medical and non-medical staff seeking to learn about the role of the family in addiction treatment are encouraged to attend. |
Topic: Addiction 101
This training will provide the foundational knowledge regarding the disease of addiction and an introduction into treatment options utilizing medications for opioid use disorder.
|
Thursday, 12/15/2022 1:00 pm – 2:00 pm ET |
|
Virtual event |
|
Intended AudienceNurses, social workers, other clinical staff, and non-clinicians. |
Topic: CARN and CARN-AP
This no-cost course reviews topics covered in the certification exam for addictions nursing and is intended to support nurses preparing to sit for the exam.
|
Thursday, 12/15/2022 4:00 pm – 8:00 pm ET |
|
Virtual event |
|
Intended AudienceRegistered Nurses (RNs) and Advanced Practice Registered Nurses (APRNs), with experience treating patients with addiction, who intend to sit for the CARN or CARN-AP exam. |
Topic: Buprenorphine
This two-part training is intended to provide eight hours of required training for providers seeking their buprenorphine waivers.
|
Friday, 12/16/2022 8:00 am – 12:00 pm ET |
|
Virtual event |
|
Intended AudiencePhysicians (MD, DO), Nurse Practitioners, Certified Nurse Midwives (CNM), Clinical Nurse Specialists (CNS), Certified Registered Nurse Anesthetists (CRNA), and Physician Assistants |
Topic: Nurse Care Manager Model
This 8-hour course prepares nurses and other medical staff to manage office-based addiction treatment with buprenorphine and naltrexone.
|
Monday, 12/19/2022 10:00 am – 2:00 pm ET |
|
Virtual event |
|
Intended AudienceNurses and other clinical staff providing treatment for substance use disorders in an office-based setting. |
Topic: Xylazine
This training will provide knowledge regarding Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US.
|
Tuesday, 12/20/2022 5:00 pm – 6:00 pm ET |
|
Virtual event |
|
Intended AudienceProviders, nurses, counselors, and other non-clinical staff are welcome to attend. |
Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.